Antal EJ - Search Results

1

Steady-state serum pharmacokinetics of novobiocin and rifampin alone and in combination.

Drusano GL, Townsend RJ, Walsh TJ, Forrest A, Antal EJ, Standiford HC. Drusano GL, et al. Among authors: antal ej. Antimicrob Agents Chemother. 1986 Jul;30(1):42-5. doi: 10.1128/AAC.30.1.42. Antimicrob Agents Chemother. 1986. PMID: 3752982 Free PMC article. Clinical Trial.

2

An evaluation of population pharmacokinetics in therapeutic trials. Part I. Comparison of methodologies.

Grasela TH Jr, Antal EJ, Townsend RJ, Smith RB. Grasela TH Jr, et al. Among authors: antal ej. Clin Pharmacol Ther. 1986 Jun;39(6):605-12. doi: 10.1038/clpt.1986.107. Clin Pharmacol Ther. 1986. PMID: 3709024 Free article.

3

Clindamycin pharmacokinetics and tissue penetration after head and neck surgery.

Stoehr GP, Yu VL, Johnson JT, Antal EJ, Townsend RJ, Wagner R. Stoehr GP, et al. Among authors: antal ej. Clin Pharm. 1988 Nov;7(11):820-4. Clin Pharm. 1988. PMID: 3197381

4

The relationship of alprazolam dose to steady-state plasma concentrations.

Ciraulo DA, Antal EJ, Smith RB, Olson DR, Goldberg DA, Rand EH, Raskin RB, Phillips JP, Shader RI, Greenblatt DJ. Ciraulo DA, et al. Among authors: antal ej. J Clin Psychopharmacol. 1990 Feb;10(1):27-32. doi: 10.1097/00004714-199002000-00005. J Clin Psychopharmacol. 1990. PMID: 2407754 Clinical Trial.

5

An evaluation of population pharmacokinetics in therapeutic trials. Part III. Prospective data collection versus retrospective data assembly.

Antal EJ, Grasela TH Jr, Smith RB. Antal EJ, et al. Clin Pharmacol Ther. 1989 Nov;46(5):552-9. doi: 10.1038/clpt.1989.185. Clin Pharmacol Ther. 1989. PMID: 2684474 Clinical Trial.

6

An evaluation of population pharmacokinetics in therapeutic trials. Part II. Detection of a drug-drug interaction.

Grasela TH Jr, Antal EJ, Ereshefsky L, Wells BG, Evans RL, Smith RB. Grasela TH Jr, et al. Among authors: antal ej. Clin Pharmacol Ther. 1987 Oct;42(4):433-41. doi: 10.1038/clpt.1987.174. Clin Pharmacol Ther. 1987. PMID: 3665341

7

Evaluation of population pharmacokinetics in therapeutic trials. IV. Application to postmarketing surveillance.

DeVane CL, Grasela TH Jr, Antal EJ, Miller RL. DeVane CL, et al. Among authors: antal ej. Clin Pharmacol Ther. 1993 May;53(5):521-8. doi: 10.1038/clpt.1993.65. Clin Pharmacol Ther. 1993. PMID: 8491063 Clinical Trial.

8

Pharmacometrics and the transition to model-based development.

Grasela TH, Dement CW, Kolterman OG, Fineman MS, Grasela DM, Honig P, Antal EJ, Bjornsson TD, Loh E. Grasela TH, et al. Among authors: antal ej. Clin Pharmacol Ther. 2007 Aug;82(2):137-42. doi: 10.1038/sj.clpt.6100270. Clin Pharmacol Ther. 2007. PMID: 17632539 Review.

9

Clinical outcome and adverse effect profile associated with concurrent administration of alprazolam and imipramine.

Wells BG, Evans RL, Ereshefsky L, Antal EJ, Lobeck F, Rawls WN, Hamann G, Grimmig J, Smith RB. Wells BG, et al. Among authors: antal ej. J Clin Psychiatry. 1988 Oct;49(10):394-9. J Clin Psychiatry. 1988. PMID: 3049560 Clinical Trial.

10

Comparison of alprazolam plasma levels in normal Asian and Caucasian male volunteers.

Lin KM, Lau JK, Smith R, Phillips P, Antal E, Poland RE. Lin KM, et al. Psychopharmacology (Berl). 1988;96(3):365-9. doi: 10.1007/BF00216063. Psychopharmacology (Berl). 1988. PMID: 3146770

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

53 results

Search Page

Filters